A MEK inhibitor arrests the cell cycle of human conjunctival fibroblasts and improves the outcome of glaucoma filtration surgery

Author:

Lee Jinhee,Honjo Megumi,Aihara Makoto

Abstract

AbstractBetter agents are needed to improve glaucoma filtration surgery outcomes compared to current ones. The purpose of this study is to determine whether mitogen-activated protein kinase kinase (MEK) inhibitors can effectively arrest the cell cycle of human conjunctival fibroblasts (HCFs) and inhibit the formation of fibrosis and scarring following glaucoma filtration surgery. A cell counting kit‑8 assay revealed that the MEK inhibitor PD0325901 exhibited concentration-dependent growth inhibition of HCFs. Quantitative PCR, immunocytochemistry, and western blotting demonstrated decreased expression of proliferating cell nuclear antigen (PCNA) and cyclin D1 and increased expression of p27 in HCFs treated with PD0325901. Flow cytometry indicated that PD0325901 arrested the cell cycle of HCFs in the G0/1 phase. The cell-migration assay showed that HCF migration rate was significantly suppressed by PD0325901 exposure. Rabbits were divided into PD0325901-treatment and control groups, and glaucoma filtration surgery was performed. Although intraocular pressure did not differ between PD0325901-treatment and control groups, bleb height was greater in the treatment group. Histopathological evaluation revealed that fibrotic changes were significantly attenuated in the PD0325901-treatment group compared to the control group. In conclusion, the MEK inhibitor impedes HCF proliferation via cell-cycle arrest and may be beneficial for glaucoma filtration surgery by reducing bleb scarring.

Funder

Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Reference43 articles.

1. Al Habash, A., Aljasim, L. A., Owaidhah, O. & Edward, D. P. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clin. Ophthalmol. 9, 1945–1951 (2015).

2. Holló, G. Wound healing and glaucoma surgery: Modulating the scarring process with conventional antimetabolites and new molecules. Dev. Ophthalmol. 59, 80–89 (2017).

3. Al-Haddad, C. E., Abdulaal, M., Al-Moujahed, A., Ervin, A. M. & Ismail, K. Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma: Findings from a Cochrane systematic review. Am. J. Ophthalmol. 174, 33–41 (2017).

4. Schlunck, G., Meyer-ter-Vehn, T., Klink, T. & Grehn, F. Conjunctival fibrosis following filtering glaucoma surgery. Exp. Eye Res. 142, 76–82 (2016).

5. Cordeiro, M. F., Bhattacharya, S. S., Schultz, G. S. & Khaw, P. T. TGF-beta1, -beta2, and -beta3 in vitro: Biphasic effects on Tenon’s fibroblast contraction, proliferation, and migration. Invest. Ophthalmol. Vis. Sci. 41, 756–763 (2000).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3